NSCLC is a heterogeneous disease and can be associated with oncogenic driver mutations activating, e.g., Epidermal Growth Factor Receptor (EGFR), Kirsten Rat Sarcoma Virus (KRAS), and Anaplastic Lymphoma Kinase (ALK) [1]. Here, KRAS is linked to non-small cell lung carcinoma.